Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas.
about
WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study.A current review of targeted therapeutics for ovarian cancer.The role of dysregulated glucose metabolism in epithelial ovarian cancer.Blocking effects of siRNA on VEGF expression in human colorectal cancer cells.Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo.Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromes.Expression of ERα, its ERαΔ3 Splice Variant and γ-SYNUCLEIN in Ovarian Cancer: A Pilot Study.Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.Role of endothelin-1 in neovascularization of ovarian carcinomaDoes VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer?Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer.Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinomaThe tumor microenvironment: key to early detection.A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.Ovarian cancer stroma: pathophysiology and the roles in cancer development.The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancerThe impact of T-cell immunity on ovarian cancer outcomes.Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells.The -137G>C polymorphism in interleukin-18 promoter region and cancer risk: evidence from a meta-analysis of 21 studies.The anti-cancer effects of itraconazole in epithelial ovarian cancerPancreatic-carcinoma-cell-derived pro-angiogenic factors can induce endothelial-cell differentiation of a subset of circulating CD34+ progenitors.The Unique Molecular and Cellular Microenvironment of Ovarian CancerAnti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model.The clinical significance of vascular endothelial growth factor in malignant ascites.Adeno-associated virus-mediated delivery of a mutant endostatin suppresses ovarian carcinoma growth in mice.Expression of interleukin-18 in human ovarian carcinoma and normal ovarian epithelium: evidence for defective processing in tumor cells.Vascular endothelial growth factor in ovarian cyst fluid.
P2860
Q33239524-80AF3F4F-2DA8-411F-83ED-AA666274EAA5Q33580998-3E54A86F-7F85-41B4-A4F4-61AD51C729C0Q33674221-58DD5311-E3C3-4FB4-BE32-2C3A17938D68Q33716283-90890A92-AF92-46AA-B8ED-1D48D2D52BF9Q34378095-BD4DD154-69AA-4A2C-80FE-19D30A27BA0FQ35104368-9AFA6708-04DF-4CC1-A7C0-3F11C71B6128Q35534334-9220B24C-8AD9-4E34-B222-EC5BE0B2FD77Q35748149-E5096A34-E7C2-47C2-AD99-6C7C33BAC956Q35829525-C9F57B66-1FBE-4691-9E2A-AC651F130E7AQ35921404-5EC226E7-67CC-4A5E-A961-39B0FC4920BCQ35954103-46663491-54F2-4559-834F-0699EA110FBEQ36414088-EBDB60C7-ED93-4F5A-AAEA-E74BC2181F3BQ36621710-3F05FD3F-13CB-4404-9F72-58CC0CC75AA0Q36627750-78EC6F07-8A65-4E8B-A917-3BDF1215F78BQ36958112-84825979-4E8C-4A3B-9E90-AACA3C0C6D75Q37017056-9362C486-D270-4845-B322-519AB2BED52FQ37022524-B9167A1C-297D-4D13-8E7D-4DD8631D03F0Q37118142-EB05DD22-5A73-4533-B91B-B92F037C6E79Q37406640-9DABA385-90DD-4A41-A735-BDA6811B203BQ38407054-E0D37555-C27F-433E-8953-5F4B9F5C41FCQ38696316-2628FDB2-7602-4FD6-B38B-569B5440E86BQ39042983-001EB0E7-D4FF-4874-BBF8-1CDBD69DAA5DQ39169603-8E16C648-A8AF-4900-BC25-0225AE4E629AQ40024233-5AD37B07-6B84-4047-BE70-8F7147576582Q40436743-8D87313C-216E-4B6A-B651-FC7682EA3E26Q40490199-2D25F0FA-8000-4DBE-A82A-EAB45676F2E8Q45885053-640C96AC-3AD9-4463-94FA-3ABB4A7096F2Q53328978-64740D30-F158-45B5-B9DF-DC0DCFD3777D
P2860
Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Vascular endothelial growth fa ...... epithelial ovarian carcinomas.
@en
type
label
Vascular endothelial growth fa ...... epithelial ovarian carcinomas.
@en
prefLabel
Vascular endothelial growth fa ...... epithelial ovarian carcinomas.
@en
P2093
P1433
P1476
Vascular endothelial growth fa ...... epithelial ovarian carcinomas.
@en
P2093
Goswitz JJ
Hartenbach EM
Mohanraj D
Ramakrishnan S
P304
P356
10.1016/S0304-3835(97)00350-9
P407
P577
1997-12-01T00:00:00Z